7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

MIRA Pharmaceuticals, Inc.
(NASDAQ:MIRA) 

MIRA stock logo

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitiv...

Founded: 2020
IPO Price: $7 (Aug 03, 2023)
CEO: Erez Aminov  
Sector: ...
Industry: Pharmaceuticals

Share this website to your friends
MIRA Pharmaceuticals . Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.38-0.33-0.27-0.22-0.16-0.11-0.050
MIRA Pharmaceuticals . Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -0.38-0.33-0.27-0.22-0.16-0.11-0.050
MIRA Pharmaceuticals . Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.060.120.180.250.310.370.43
MIRA Pharmaceuticals . (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -6.87-5.89-4.91-3.93-2.94-1.96-0.980
MIRA Pharmaceuticals . P/B ratio ttm
202311 202312 202401 202402 202403 202404 00.911.822.743.654.565.476.39
No extra charts and metrics for this ticker.